KCNJ11 mutations can present with a broad clinical spectrum, including transient or permanent neonatal diabetes, MODY-like diabetes in childhood or early adulthood, type 2 diabetes phenotypes, and congenital hyperinsulinism. The gene discussed is KCNJ11; the disease is type 2 diabetes mellitus.